D
David C.W. Lau
Researcher at University of Calgary
Publications - 145
Citations - 10939
David C.W. Lau is an academic researcher from University of Calgary. The author has contributed to research in topics: Diabetes mellitus & Weight loss. The author has an hindex of 34, co-authored 129 publications receiving 9653 citations. Previous affiliations of David C.W. Lau include University of Ottawa & Libin Cardiovascular Institute of Alberta.
Papers
More filters
Journal ArticleDOI
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer,Arne Astrup,Ken Fujioka,Frank L. Greenway,Alfredo Halpern,Michel Krempf,David C.W. Lau,Carel W. le Roux,Rafael Violante Ortiz,Christine B. Jensen,John P.H. Wilding +10 more
TL;DR: 3.0 mg of liraglutide, as an adjunct to diet and exercise, was associated with reduced body weight and improved metabolic control in patients with type 2 diabetes and prediabetes.
Journal ArticleDOI
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]
David C.W. Lau,James D. Douketis,Katherine M. Morrison,Irene M. Hramiak,Arya M. Sharma,Ehud Ur +5 more
TL;DR: Over the last 20 years, obesity has become the most prevalent nutritional problem in the world, eclipsing undernutrition and infectious disease.
Journal ArticleDOI
Adipokines: molecular links between obesity and atheroslcerosis.
TL;DR: The role of adipose tissue in the development of obesity-linked insulin resistance, metabolic syndrome, and diabetes will be reviewed, including an examination of the molecular links between obesity and atherosclerosis, namely, the effects of fat-derived adipokines.
Journal ArticleDOI
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Todd J. Anderson,Jean Grégoire,Glen J. Pearson,Arden R. Barry,Patrick Couture,Martin Dawes,Gordon A. Francis,Jacques Genest,Steven A. Grover,Milan Gupta,Milan Gupta,Robert A. Hegele,David C.W. Lau,Lawrence A. Leiter,Eva Lonn,G.B. John Mancini,Ruth McPherson,Daniel Ngui,Paul Poirier,John L. Sievenpiper,James A. Stone,George Thanassoulis,Richard Ward +22 more
TL;DR: Risk assessment and lipid determination should be considered in individuals older than 40 years of age or in those at increased risk regardless of age, and recommendation for the use of nonstatin medications is provided.
Journal ArticleDOI
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations
Jacques Genest,Ruth McPherson,Jiri Frohlich,Todd J. Anderson,Norm R.C. Campbell,André C. Carpentier,Patrick Couture,Robert Dufour,George Fodor,Gordon A. Francis,Steven A. Grover,Milan Gupta,Robert A. Hegele,David C.W. Lau,Lawrence A. Leiter,Gary F. Lewis,Eva Lonn,G.B. John Mancini,Dominic S. Ng,Glen J. Pearson,Allan D. Sniderman,James A. Stone,Ehud Ur +22 more
TL;DR: The present article represents the 2009 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult.